Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,800.00
Bid: 4,798.00
Ask: 4,802.00
Change: 24.00 (0.50%)
Spread: 4.00 (0.083%)
Open: 4,826.00
High: 4,842.00
Low: 4,766.00
Prev. Close: 4,776.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

10 Apr 2008 07:00

Intertek Group PLC10 April 2008 Stock Exchange Release 10 April 2008, 7am London, UK Intertek acquires 4-Front Research Intertek Group plc (Intertek), the leading provider of quality and safetysolutions to a wide range of industries around the world, announces theacquisition of 4-Front Research Limited, 4-Front Research UK Limited, 4 FrontResearch SAS (France) and Four Front Research (India) Pvt Limited), (together"4-Front Research"), a provider of testing services for consumer healthcare andrelated products. Intertek purchased 4-Front Research from owner Jon Holt for an initial cashconsideration of GBP 6 million and an estimated deferred consideration of GBP4.4 million payable in June 2009, and based on 2008 performance. 4-Front Research provides analytical support for clinical research studies oncosmetic, personal care, functional food, and over-the-counter (OTC)pharmaceutical and medical products. Customers, which include national andinternational consumer product brands, use 4-Front Research's services forproduct development, support, and to verify promotional statements. Products areevaluated for dermatological, allergenic, sunlight or dental effects amongstothers. With seven sites in England and sites in Hyderabad, India and Paris, France,4-Front employs 110 people and will form part of Intertek's Consumer Goodsdivision. Wolfhart Hauser, Chief Executive Officer of Intertek, commented: "4-Front Research adds new high-value services to support our consumerhealthcare customers in helping them to develop and monitor products. Theacquisition also gives us a strategic position to support future and growingdemand for consumer healthcare products within India and other Asian marketswith its locations in India, supported by the European network." -ends- Contacts Aston Swift / Sarah Ogilvie Intertek Telephone: +44 (0) 20 7396 3400 aston.swift@intertek.com / sarah.ogilvie@intertek.com Richard Mountain / Sophie Kernon, Financial Dynamics Telephone: +44 (0) 20 7269 7121 richard.mountain@fd.com / sophie.kernon@fd.com Notes to Editors ABOUT INTERTEK Intertek (LSE: ITRK) is a leading provider of quality and safety solutions serving a wide range of industries around the world. From auditing and inspection, to testing, quality assurance and certification, Intertek people are dedicated to adding value to customers' products and processes, supporting their success in the global marketplace. Intertek has the expertise, resources and global reach to support its customers through its network of more than 1,000 laboratories and offices and over 21,000 people in 110 countries around the world. www.intertek.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Mar 20181:00 pmRNSTotal Voting Rights
1st Feb 20181:00 pmRNSTotal Voting Rights
2nd Jan 20181:00 pmRNSTotal Voting Rights
21st Dec 20171:00 pmRNSDirector Declaration
13th Dec 20171:00 pmRNSBoard Committee changes
13th Dec 20177:00 amRNSAcquisition
1st Dec 20171:00 pmRNSTotal Voting Rights
21st Nov 20171:00 pmRNSBlock listing Interim Review
21st Nov 20177:00 amRNSTrading Statement
1st Nov 20171:00 pmRNSTotal Voting Rights
2nd Oct 20171:00 pmRNSDirectorate Change
2nd Oct 20171:00 pmRNSTotal Voting Rights
1st Sep 20171:00 pmRNSTotal Voting Rights
11th Aug 20173:30 pmRNSDirector/PDMR Shareholding
8th Aug 20171:00 pmRNSDirector/PDMR Shareholding
1st Aug 20171:00 pmRNSTotal Voting Rights
1st Aug 20177:00 amRNSHalf-year Report
27th Jul 20171:35 pmRNSDirectorate Change
12th Jul 20171:00 pmRNSDirector Declaration
10th Jul 20173:00 pmRNSDirector Declaration
3rd Jul 201712:59 pmRNSTotal Voting Rights
23rd Jun 20171:00 pmRNSDirectorate Change
1st Jun 20171:00 pmRNSTotal Voting Rights
31st May 20171:00 pmRNSHolding(s) in Company
30th May 20171:01 pmRNSHolding(s) in Company
30th May 20171:00 pmRNSDirector/PDMR Shareholding
26th May 201710:21 amRNSResult of AGM
26th May 20177:00 amRNSTrading Statement
25th May 20171:00 pmRNSHolding(s) in Company
24th May 20177:00 amRNSDirectorate Change
22nd May 20171:00 pmRNSBlock listing Interim Review
3rd May 20171:00 pmRNSHolding(s) in Company
2nd May 20171:00 pmRNSTotal Voting Rights
10th Apr 20171:00 pmRNSHolding(s) in Company
7th Apr 20177:00 amRNSAcquisition
3rd Apr 20171:00 pmRNSTotal Voting Rights
23rd Mar 20177:00 amRNSAnnual Financial Report
21st Mar 20172:04 pmRNSAdditional Directorship Notification
21st Mar 20171:02 pmRNSDirector/PDMR Shareholding
13th Mar 20173:00 pmRNSDirector/PDMR Shareholding
13th Mar 20173:00 pmRNSDirector/PDMR Shareholding
7th Mar 20177:00 amRNSFinal Results
2nd Mar 20171:00 pmRNSDirectorate Change
2nd Mar 20171:00 pmRNSHolding(s) in Company
1st Mar 20171:00 pmRNSTotal Voting Rights
1st Feb 20171:00 pmRNSTotal Voting Rights
3rd Jan 20171:00 pmRNSTotal Voting Rights
28th Dec 20161:00 pmRNSHolding(s) in Company
1st Dec 20161:00 pmRNSTotal Voting Rights
22nd Nov 20161:00 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.